Every one of those 1 sits in a single category, market-trends. Reed's Inc is most often covered alongside Intrusion Inc., which appears in 1 of these 1 story. Each story carries 3 original sources on average, compared with 2.4 for the broader beat in this window.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about Reed's Inc
Every one of those 1 sits in a single category, market-trends. Reed's Inc is most often covered alongside Intrusion Inc., which appears in 1 of these 1 story. Each story carries 3 original sources on average, compared with 2.4 for the broader beat in this window. Their average consequence score of 5 runs below the beat's 5.8 for that window. Reed's Inc appears in 1 tracked Healthcare story from March 24, 2026.
Stories tracked
1
Sources per story
3
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 29 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering Reed's Inc. Shared-story counts are live from our verified record — not editorial picks.
TELA Bio and Intrusion Inc. reported their Q4 and full-year 2025 financial results, highlighting growth in soft tissue reconstruction and advanced cybersecurity solutions. These reports, alongside a leadership transition at Reed's Inc., underscore the evolving landscape of medical technology and data protection in the healthcare sector.